Vincent Lotteau
10Patents
3h-index
18Co-inventors
53Inventor score
Filing activity: Jun 19, 2001 → Feb 19, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9695446B2 | Direct protein delivery with engineered microvesicles | Chemistry; Metallurgy | 16 | Active |
| US8697439B2 | Direct protein delivery with engineered microvesicles | Chemistry; Metallurgy | 13 | Active |
| US6548295B2 | Complex of lipo-viro-particles, method of preparation and applications | Chemistry; Metallurgy | 3 | Expired |
| US6506555B1 | Use of HIV protease inhibiting compounds | Human Necessities | 1 | Expired |
| US9895380B2 | Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection | Human Necessities | 1 | Active |
| US10071108B2 | Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection | Human Necessities | 0 | Active |
| US7259012B2 | Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cells | Chemistry; Metallurgy | 0 | Expired |
| US8716020B2 | Reprogrammation of eukaryotic cells with engineered microvesicles | Chemistry; Metallurgy | 0 | Active |
| US9168236B2 | Methods and pharmaceutical compositions for inhibiting influenza viruses replication | Human Necessities | 0 | Active |
| US7368287B2 | Use of L-α-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.